Nike's stock has dropped 75% over five years, pushing its dividend yield close to 5%, signaling market concerns. The company hopes to replicate Michael Jordan's past success by launching the Caitlin 1, its largest women's signature shoe, which sold out quickly and sparked strong demand. Despite this, Nike faces challenges including shrinking revenue, a deliberate cutback on Jordan brand products due to oversupply, and ongoing restructuring. The growth in women's basketball shoes is promising, but one product alone cannot reverse the company's overall decline. Investors should watch upcoming sales, product releases, and Nike's investor day for clearer dividend outlooks.
Nike's dividend yield stands at a notable 4.63% as of Oct 02, 2026 21:41 WIB, reflecting investor attention on its income potential despite recent challenges. On Pluang, Nike's stock price is USD 33.40, down 4.98% for the day, with a market cap of $52.14 billion and a typical hold time of 155 days. This trading activity highlights cautious optimism as the company navigates restructuring and product shifts, including the launch of the Caitlin 1 shoe.
UBS has maintained a Neutral rating on Nike stock following the company's fiscal first-quarter revenue falling short of estimates and its announcement of layoffs. Nike's shares dropped over 7% amid weak earnings guidance and expectations of further s...
Nike shares fell below their 52-week low amid a shrinking sales outlook and challenges in China, with revenue expected to decline in fiscal 2027. Despite this, Piper Sandler analyst Abbie Zvejnieks rates Nike as Overweight with a $75 price target, im...
Nike's shares fell over 8% following a weaker-than-expected first-quarter revenue report, largely impacted by struggles in its China market. The company announced a restructuring plan that includes layoffs next year and forecasted a high-single-digit...
Nike reported a 4% decline in Q1 sales, driven by a 22% drop in China revenue, impacting its overall performance and leading to a 9% premarket share decline. Moderna will replace Warner Bros Discovery in the Nasdaq-100, reflecting its strong market p...
Nike reported a 26% revenue decline in China and missed revenue expectations in its FY1Q27 results, though earnings slightly beat estimates. The company guided for a high single-digit revenue decline in FY2027, citing challenges like strong competiti...
